Concepedia

Publication | Open Access

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

DOIFull Paper Access

25

Citations

12

References

2018

Year

Robert Olson, Mitchell Liu, Alanah Bergman, Sonya Lam, Fred Hsu, Benjamin Mou, Tanya Berrang, Ante Mestrovic, Nick Chng, Derek Hyde,
BMC Cancer

Abstract

Registered through clinicaltrials.gov NCT02933242 on October 14, 2016 prospectively before patient accrual.

References

YearCitations

Page 1